An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough.

Rayid AbdulqawiImran Satia Kimberley J Holt Rachel J DockryShilpi SenJaclyn Ann Smith

Published in: ERJ open research (2021)

Blocking NMDA receptors with memantine in refractory chronic cough patients is poorly tolerated and demonstrates no improvement in cough https://bit.ly/3kgx2g1.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
open label
randomized controlled trial
clinical trial
patient reported
study protocol
placebo controlled